Clinical observation of acupoint application therapy combined with Jinzhen oral liquid in the treatment of pediatric bronchopneumonia

Objective: Observe the clinical efficacy of acupoint application therapy combined with Jinzhen oral liquid in the treatment of pediatric bronchopneumonia. Method: Sixty children with bronchopneumonia admitted to the Second Affiliated Hospital of Xingtai Medical College from December 2022 to June 2023 were selected as the research subjects and randomly divided into two groups, with 30 cases in each group. The control group was treated with amoxicillin and potassium clavulanate granules, while the combination group was treated with acupoint patches and Jinzhen oral liquid in addition to the control group. After one week of intervention, compare the improvement of traditional Chinese medicine syndrome scores, clinical efficacy, and adverse reactions between the two groups. Result: The improvement of traditional Chinese medicine syndrome scores in the combined group of patients after treatment was better than that in the control group, and the difference was statistically significant (P<0.05); The total effective rate of the combination group treatment (93.33%) was higher than that of the control group (73.33%), and P<0.05; There was no statistically significant difference (P>0.05) in the comparison of adverse reactions between the two groups of pediatric patients. Conclusion: Acupoint application combined with Jinzhen oral liquid can further improve symptoms and enhance clinical efficacy in children with bronchopneumonia, and has high safety.